All Stories

  1. Stability and aggregation propensity do not fully account for the association of various germline variable domain gene segments with light chain amyloidosis

    Article • Biological Chemistry, January 2017, De Gruyter

    Dr Jorge Melendez-Zajgla

  2. Transcriptome profile of the early stages of breast cancer tumoral spheroids

    Article • Scientific Reports, March 2016, Nature

    Dr Jorge Melendez-Zajgla

  3. Probenecid Sensitizes Neuroblastoma Cancer Stem Cells to Cisplatin

    Article • Cancer Investigation, March 2016, Taylor & Francis

    Dr Jorge Melendez-Zajgla

  4. Tissue inhibitor of metalloproteinases-4 (TIMP-4) regulates stemness in cervical cancer cells

    Article • Molecular Carcinogenesis, November 2015, Wiley

    Dr Jorge Melendez-Zajgla

  5. Epigenetic silencing of the XAF1 gene is mediated by the loss of CTCF binding

    Article • Scientific Reports, October 2015, Nature

    Dr Jorge Melendez-Zajgla

  6. Particulate matter (PM10) induces metalloprotease activity and invasion in airway epithelial cells

    Article • Toxicology Letters, September 2015, Elsevier

    Professor Alvaro R Osornio Vargas, Dr Jorge Melendez-Zajgla

  7. NF-κB signaling in cancer stem cells: a promising therapeutic target?

    Article • Cellular Oncology, August 2015, Springer Science + Business Media

    Dr Jorge Melendez-Zajgla

  8. Tissue Inhibitor of Metalloproteinase-4 Triggers Apoptosis in Cervical Cancer Cells

    Article • PLoS ONE, August 2015, PLOS

    Dr Jorge Melendez-Zajgla

  9. Induction of c-Jun by air particulate matter (PM10) of Mexico city: Participation of polycyclic aromatic hydrocarbons

    Article • Environmental Pollution, August 2015, Elsevier

    Professor Alvaro R Osornio Vargas, Dr Jorge Melendez-Zajgla

  10. Tissue inhibitor of metalloproteases-4 (TIMP-4) modulates adipocyte differentiation in vitro

    Article • Experimental Cell Research, July 2015, Elsevier

    Dr Jorge Melendez-Zajgla

  11. Complementary genomic approaches highlight the PI3K/mTOR pathway as a common vulnerability in osteosarcoma

    Article • Proceedings of the National Academy of Sciences, December 2014, Proceedings of the National Academy of Sciences

    Dr Jorge Melendez-Zajgla

  12. Abstract A41: Complementary genomic approaches highlight the PI3K/mTOR pathway as a common vulnerability in osteosarcoma

    Article • Cancer Research, October 2014, American Association for Cancer Research (AACR)

    Dr Jorge Melendez-Zajgla

  13. SerpinA3g participates in the antiadipogenesis and insulin-resistance induced by tumor necrosis factor-α in 3T3-F442A cells

    Article • Cytokine, October 2014, Elsevier

    Dr Jorge Melendez-Zajgla

  14. Increased expression of prostaglandin reductase 1 in hepatocellular carcinomas from clinical cases and experimental tumors in rats

    Article • The International Journal of Biochemistry & Cell Biology, August 2014, Elsevier

    Dr Jorge Melendez-Zajgla

  15. Laser capture microdissection after γ-glutamyl transferase histochemistry: An optimization for gene expression analysis

    Article • Analytical Biochemistry, February 2014, Elsevier

    Dr Jorge Melendez-Zajgla

  16. Landscape of genomic alterations in cervical carcinomas

    Article • Nature, December 2013, Nature

    Dr Jorge Melendez-Zajgla, Dr Alfredo Hidalgo-Miranda

  17. Mutational heterogeneity in cancer and the search for new cancer-associated genes

    Article • Nature, June 2013, Nature

    Dr Jorge Melendez-Zajgla, Dr Alfredo Hidalgo-Miranda

  18. DIABLO (diablo, IAP-binding mitochondrial protein)

    Article • Atlas of Genetics and Cytogenetics in Oncology and Haematology, June 2013, INIST-CNRS

    Dr Jorge Melendez-Zajgla

  19. Abstract 4604: Landscape of human and viral genomic alterations in cervical carcinomas.

    Article • Cancer Research, April 2013, American Association for Cancer Research (AACR)

    Dr Jorge Melendez-Zajgla

  20. Bcl-3 regulates UVB-induced apoptosis

    Article • Human Cell, March 2013, Springer Science + Business Media

    Dr Jorge Melendez-Zajgla

  21. Abstract PL07-01: Molecular profiling of breast cancer in Mexico: Identification of novel therapeutic targets through whole genome sequencing analysis.

    Article • Cancer Epidemiology Biomarkers & Prevention, October 2012, American Association for Cancer Research (AACR)

    Dr Jorge Melendez-Zajgla

  22. Sequence analysis of mutations and translocations across breast cancer subtypes

    Article • Nature, June 2012, Springer Science + Business Media

    Dr Jorge Melendez-Zajgla, Dr Alfredo Hidalgo-Miranda

  23. Survivin isoform Delta Ex3 regulates tumor spheroid formation

    Article • Cancer Letters, May 2012, Elsevier

    Dr Jorge Melendez-Zajgla

  24. Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing

    Article • Proceedings of the National Academy of Sciences, February 2012, Proceedings of the National Academy of Sciences

    Dr Jorge Melendez-Zajgla, Dr Alfredo Hidalgo-Miranda

  25. Probenecid is a chemosensitizer in cancer cell lines

    Article • Cancer Chemotherapy and Pharmacology, August 2011, Springer Science + Business Media

    Dr Jorge Melendez-Zajgla

  26. The Mutational Landscape of Head and Neck Squamous Cell Carcinoma

    Article • Science, July 2011, American Association for the Advancement of Science

    Dr Jorge Melendez-Zajgla, Dr Aleksandar D Kostic, Dr Alfredo Hidalgo-Miranda

  27. Renin is an angiotensin-independent profibrotic mediator: role in pulmonary fibrosis

    Article • European Respiratory Journal, June 2011, European Respiratory Society (ERS)

    Dr Jorge Melendez-Zajgla

  28. Role of Bcl-3 in solid tumors

    Article • Molecular Cancer, January 2011, Springer Science + Business Media

    Dr Jorge Melendez-Zajgla

  29. Paradoxial changes in the expression of estrogen receptor alpha in breast cancer multicellular spheroids

    Article • Tissue and Cell, October 2010, Elsevier

    Dr Jorge Melendez-Zajgla, Dr Alfredo Hidalgo-Miranda

  30. Depletion of the oncoprotein Bcl-3 induces centrosome amplification and aneuploidy in cancer cells

    Article • Molecular Cancer, January 2010, Springer Science + Business Media

    Dr Jorge Melendez-Zajgla

  31. NF-kappa B is required for the development of tumor spheroids

    Article • Journal of Cellular Biochemistry, September 2009, Wiley

    Dr Jorge Melendez-Zajgla, Professor Rafael Moreno-Sanchez

  32. Renoprotection byα-mangostin is related to the attenuation in renal oxidative/nitrosative stress induced by cisplatin nephrotoxicity

    Article • Free Radical Research, January 2009, Taylor & Francis

    Dr Jorge Melendez-Zajgla

  33. Participation of Omi Htra2 Serine-Protease Activity in the Apoptosis Induced by Cisplatin on SW480 Colon Cancer Cells

    Article • Journal of Chemotherapy, June 2008, Taylor & Francis

    Dr Jorge Melendez-Zajgla

  34. Nuclear Factor-kappa B as a Resistance Factor to Platinum-Based Antineoplasic Drugs

    Article • Metal-Based Drugs, January 2008, Hindawi Publishing Corporation

    Dr Jorge Melendez-Zajgla

  35. Tissue Inhibitor of Metalloproteinases-4. The road less traveled

    Article • Molecular Cancer, January 2008, Springer Science + Business Media

    Dr Jorge Melendez-Zajgla

  36. Role of Smac/DIABLO in cancer progression

    Article • Journal of Experimental & Clinical Cancer Research, January 2008, Springer Science + Business Media

    Dr Jorge Melendez-Zajgla

  37. Is digitalis compound-induced cardiotoxicity, mediated through guinea-pig cardiomyocytes apoptosis?

    Article • European Journal of Pharmacology, July 2007, Elsevier

    Dr Jorge Melendez-Zajgla

  38. Regulation of mitochondrial Smac/DIABLO-selective release by survivin

    Article • Oncogene, June 2007, Nature

    Dr Jorge Melendez-Zajgla

  39. Apoptosis induced by cAMP requires Smac/DIABLO transcriptional upregulation

    Article • Cellular Signalling, June 2007, Elsevier

    Dr Jorge Melendez-Zajgla

  40. Apoptosis induced by cisplatin but not by 5-FU in colon cancer cells depends on Omi/Htra2 protein

    Article • BMC Cancer, January 2007, Springer Science + Business Media

    Dr Jorge Melendez-Zajgla

  41. Benzene metabolites induce apoptosis in lymphocytes

    Article • Experimental and Toxicologic Pathology, August 2006, Elsevier

    Dr Jorge Melendez-Zajgla

  42. NF-κB does not influence the induction of apoptosis by Ukrain

    Article • Cancer Biology & Therapy, July 2006, Taylor & Francis

    Dr Jorge Melendez-Zajgla

  43. External membrane vesicles from Helicobacter pylori induce apoptosis in gastric epithelial cells

    Article • FEMS Microbiology Letters, July 2006, Oxford University Press (OUP)

    Dr Jorge Melendez-Zajgla

  44. Proliferation and apoptosis of HeLa cells induced by in vitro stimulation with digitalis

    Article • European Journal of Pharmacology, March 2006, Elsevier

    Dr Jorge Melendez-Zajgla

  45. Oxaliplatin activity in head and neck cancer cell lines

    Article • Cancer Chemotherapy and Pharmacology, October 2004, Springer Science + Business Media

    Dr Jorge Melendez-Zajgla

  46. Tissue inhibitor of metalloproteinases-2 growth-stimulatory activity is mediated by nuclear factor-kappa B in A549 lung epithelial cells

    Article • The International Journal of Biochemistry & Cell Biology, August 2004, Elsevier

    Dr Jorge Melendez-Zajgla

  47. Cupressus lusitanica (Cupressaceae) leaf extract induces apoptosis in cancer cells

    Article • Journal of Ethnopharmacology, May 2002, Elsevier

    Dr Jorge Melendez-Zajgla

  48. Estrogen receptor expression in giant cell tumors of the bone

    Article • Human Pathology, February 2002, Elsevier

    Dr Jorge Melendez-Zajgla

  49. Gemcitabine activity in cervical cancer cell lines

    Article • Cancer Chemotherapy and Pharmacology, December 2001, Springer Science + Business Media

    Dr Jorge Melendez-Zajgla

  50. Inhibitor of apoptosis-1 (IAP-1) expression and apoptosis in non-small-cell lung cancer cells exposed to gemcitabine11Abbreviations: IAP, inhibitor of apoptosis; TNF-α, tumor necrosis factor-α; NF-κB, nuclear factor-κB; RT-PCR, reverse transcriptase-po...

    Article • Biochemical Pharmacology, July 2001, Elsevier

    Dr Jorge Melendez-Zajgla

  51. Weekly Cisplatin/Low-Dose Gemcitabine Combination for Advanced and Recurrent Cervical Carcinoma

    Article • American Journal of Clinical Oncology, April 2001, Wolters Kluwer Health

    Dr Jorge Melendez-Zajgla

  52. Mitochondrial changes during the apoptotic process of HeLa cells exposed to cisplatin

    Article • IUBMB Life, May 1999, Wiley

    Dr Jorge Melendez-Zajgla

  53. Gelatinases A and B Are Up-Regulated in Rat Lungs by Subacute Hyperoxia

    Article • American Journal Of Pathology, September 1998, Elsevier

    Dr Jorge Melendez-Zajgla

  54. Modulation of NF-κB, p53 and Bcl-2 in apoptosis induced by cisplatin in HeLa cells

    Article • Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, November 1997, Elsevier

    Dr Jorge Melendez-Zajgla

  55. Subcellular redistribution of hsp72 protein during cisplatin-induced apoptosis in HeLa cells

    Article • IUBMB Life, October 1996, Wiley

    Dr Jorge Melendez-Zajgla

  56. Effect of melatonin on β-tubulin and MAP2 expression in NIE-115 cells

    Article • Neurochemical Research, June 1996, Springer Science + Business Media

    Dr Jorge Melendez-Zajgla

  57. Paclitaxel-induced apoptosis in HeLa cells is serum dependent

    Article • Journal of Biochemical Toxicology, January 1996, Wiley

    Dr Jorge Melendez-Zajgla

  58. Paclitaxel‐induced apoptosis in HeLa cells is serum dependent

    Article • Journal of Biochemical Toxicology, January 1996, Wiley

    Dr Jorge Melendez-Zajgla

  59. Regulation of apo B mRNA expression in liver and intestine during liver regeneration induced by CCl4

    Article • Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, February 1994, Elsevier

    Dr Jorge Melendez-Zajgla